tirzepatide body composition CagriSema vs tirzepatide: which next-generation weight loss treatment wins? Retatrutide vs. Tirzepatide vs. Semaglutide

About Galen Growth Galen Growth is the digital health intelligence firm behind HealthTech Alpha, the leading ontology-driven platform tracking the global digital health ecosystem

The FDA hasn't reviewed compounded versions for safety, effectiveness, or manufacturing quality as finished drug products

Virtual Care How can I get prescribed a GLP-1 medication in Florida

Tirzepatide Shows Promise in Treating MASH: Key Findings from the SYNERGY-NASH Study Dave Knapp Jun 12, 2024 2 min read Significant Results in MASH Treatment Eli Lilly recently announced the results of their phase 2 SYNERGY-NASH study, which investigated the use of tirzepatide in treating metabolic dysfunction-associated steatohepatitis (MASH) with stage 2 or 3 fibrosis

Why is the body mass index lost with diet, bariatric surgery, and GLP-1 receptor agonist therapy proportional to the treatment duration

Many patients need to remain on GLP-1 medicines long term to sustain weight loss and preserve other health benefits, including lower cardiovascular risks